BCM
OLMA icon

Bridgeway Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Bridgeway Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,000
Closed -$373K – 1290
2026
Q1 		$373K Sell
25,000
-15,500
-38% -$345K 0.01% 883
2025
Q4 		$1.01M Sell
40,500
-29,500
-42% -$525K 0.02% 703
2025
Q3 		$685K Buy
70,000
+20,000
+40% +$120K 0.01% 753
2025
Q2 		$213K Buy
+50,000
New +$223K 0.01% 949
2023
Q4 		– Sell
-86,487
Closed -$1.07M – 1404
2023
Q3 		$1.07M Sell
86,487
-29,200
-25% -$298K 0.03% 694
2023
Q2 		$1.04M Hold
115,687
– – 0.03% 719
2023
Q1 		$401K Sell
115,687
-22,000
-16% -$89.7K 0.01% 933
2022
Q4 		$337K Buy
137,687
+8,100
+6% +$23.6K 0.01% 967
2022
Q3 		$358K Buy
+129,587
New +$550K 0.01% 984

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Bridgeway Capital Management's OLMA Position: Q2 2026 in Review

Bridgeway Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 25,000 shares — an estimated $373K sold.

Bridgeway Capital Management first reported a position in OLMA in Q3 2022 and held it in 9 quarters. The position peaked at $1.07M in Q3 2023. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Bridgeway Capital Management reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 25,000 Olema Pharmaceuticals shares in Q2 2026, an estimated $373K.
  • Bridgeway Capital Management first reported a position in Olema Pharmaceuticals in Q3 2022 and held it in 9 quarters.
  • Bridgeway Capital Management's Olema Pharmaceuticals position peaked at $1.07M in Q3 2023.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.